Water Research, ISSN 0043-1354, 2011, Volume 45, Issue 11, pp. 3417 - 3426
This work examined the sorption potential to wastewater primary- and activated-sludge solids for 34 emerging trace organic chemicals at environmentally...
Sorption | Personal care products | Pharmaceutically-active compounds | Household chemicals | Steroidal hormones | Inactivation | Wastewater treatment | Primary and activated sludge | SEWAGE-SLUDGE | CHROMATOGRAPHY/TANDEM MASS-SPECTROMETRY | COEFFICIENT K-D | ACTIVATED-SLUDGE | MUSK FRAGRANCES | WATER RESOURCES | ENVIRONMENTAL SCIENCES | ENDOCRINE DISRUPTORS | ENGINEERING, ENVIRONMENTAL | TREATMENT PLANTS | FLUOROQUINOLONE ANTIBACTERIAL AGENTS | BETA-BLOCKERS | Amitriptyline - chemistry | Household Products - analysis | Sewage - chemistry | Hydroxyzine - analysis | Cosmetics - chemistry | Organic Chemicals - chemistry | Water Pollutants, Chemical - chemistry | Hydroxyzine - chemistry | Risperidone - chemistry | Waste Disposal, Fluid | Water Pollutants, Chemical - analysis | Organic Chemicals - analysis | Verapamil - chemistry | Amitriptyline - analysis | Risperidone - analysis | Adsorption | Clozapine - chemistry | Verapamil - analysis | Cosmetics - analysis | Pharmaceutical Preparations - chemistry | Pharmaceutical Preparations - analysis | Clozapine - analysis | Mathematical models | Hydrophobicity | Hormones | Sludge | Organic compounds | Waste water
Sorption | Personal care products | Pharmaceutically-active compounds | Household chemicals | Steroidal hormones | Inactivation | Wastewater treatment | Primary and activated sludge | SEWAGE-SLUDGE | CHROMATOGRAPHY/TANDEM MASS-SPECTROMETRY | COEFFICIENT K-D | ACTIVATED-SLUDGE | MUSK FRAGRANCES | WATER RESOURCES | ENVIRONMENTAL SCIENCES | ENDOCRINE DISRUPTORS | ENGINEERING, ENVIRONMENTAL | TREATMENT PLANTS | FLUOROQUINOLONE ANTIBACTERIAL AGENTS | BETA-BLOCKERS | Amitriptyline - chemistry | Household Products - analysis | Sewage - chemistry | Hydroxyzine - analysis | Cosmetics - chemistry | Organic Chemicals - chemistry | Water Pollutants, Chemical - chemistry | Hydroxyzine - chemistry | Risperidone - chemistry | Waste Disposal, Fluid | Water Pollutants, Chemical - analysis | Organic Chemicals - analysis | Verapamil - chemistry | Amitriptyline - analysis | Risperidone - analysis | Adsorption | Clozapine - chemistry | Verapamil - analysis | Cosmetics - analysis | Pharmaceutical Preparations - chemistry | Pharmaceutical Preparations - analysis | Clozapine - analysis | Mathematical models | Hydrophobicity | Hormones | Sludge | Organic compounds | Waste water
Journal Article
BBA - Biomembranes, ISSN 0005-2736, 2011, Volume 1808, Issue 8, pp. 2009 - 2018
The interaction of antipsychotic drugs (AP) with lipids and the subsequent lipid reorganization on model membranes was assessed using a combination of several...
Differential scanning calorimetry | Docking calculations | Antipsychotic drugs | Membrane domains | Fluorescence microscopy | Plasmon waveguide resonance | BILAYER-MEMBRANES | BIOCHEMISTRY & MOLECULAR BIOLOGY | X-RAY-DIFFRACTION | ANTIMICROBIAL PEPTIDES | THERMOTROPIC PHASE-BEHAVIOR | CHLORPROMAZINE | BIOPHYSICS | CHOLESTEROL HOMEOSTASIS | BINDING-PROPERTIES | PHOSPHATIDYLCHOLINE | Surface Plasmon Resonance | Molecular Conformation | Structure-Activity Relationship | Membrane Lipids - chemistry | Pyrimidines - chemistry | Cell Membrane - chemistry | Cholesterol - chemistry | X-Ray Diffraction | Receptors, Dopamine D2 - chemistry | 1,2-Dipalmitoylphosphatidylcholine - chemistry | Molecular Structure | Dopamine Antagonists - chemistry | Haloperidol - pharmacology | Cell Membrane - drug effects | Paliperidone Palmitate | Risperidone - pharmacology | Membranes, Artificial | Models, Molecular | Risperidone - chemistry | Isoxazoles - chemistry | Phosphatidylcholines - chemistry | Pyrimidines - pharmacology | Haloperidol - chemistry | Isoxazoles - pharmacology | Antipsychotic Agents - chemistry | Dopamine Antagonists - pharmacology | Calorimetry, Differential Scanning | Sphingomyelins - chemistry | Antipsychotic Agents - pharmacology | Dopamine D2 Receptor Antagonists | Microscopy, Fluorescence
Differential scanning calorimetry | Docking calculations | Antipsychotic drugs | Membrane domains | Fluorescence microscopy | Plasmon waveguide resonance | BILAYER-MEMBRANES | BIOCHEMISTRY & MOLECULAR BIOLOGY | X-RAY-DIFFRACTION | ANTIMICROBIAL PEPTIDES | THERMOTROPIC PHASE-BEHAVIOR | CHLORPROMAZINE | BIOPHYSICS | CHOLESTEROL HOMEOSTASIS | BINDING-PROPERTIES | PHOSPHATIDYLCHOLINE | Surface Plasmon Resonance | Molecular Conformation | Structure-Activity Relationship | Membrane Lipids - chemistry | Pyrimidines - chemistry | Cell Membrane - chemistry | Cholesterol - chemistry | X-Ray Diffraction | Receptors, Dopamine D2 - chemistry | 1,2-Dipalmitoylphosphatidylcholine - chemistry | Molecular Structure | Dopamine Antagonists - chemistry | Haloperidol - pharmacology | Cell Membrane - drug effects | Paliperidone Palmitate | Risperidone - pharmacology | Membranes, Artificial | Models, Molecular | Risperidone - chemistry | Isoxazoles - chemistry | Phosphatidylcholines - chemistry | Pyrimidines - pharmacology | Haloperidol - chemistry | Isoxazoles - pharmacology | Antipsychotic Agents - chemistry | Dopamine Antagonists - pharmacology | Calorimetry, Differential Scanning | Sphingomyelins - chemistry | Antipsychotic Agents - pharmacology | Dopamine D2 Receptor Antagonists | Microscopy, Fluorescence
Journal Article
Drug Metabolism and Disposition, ISSN 0090-9556, 05/2016, Volume 44, Issue 5, pp. 634 - 646
Replacement of hydrogen with fluorine is a useful drug design strategy when decreases in cytochrome P450 (P450) metabolic lability are needed. In this paper, a...
MEDICINAL CHEMISTRY | PHENOLS | RAMELTEON | PHARMACOLOGY & PHARMACY | RISPERIDONE | EXCRETION | MIDAZOLAM | Magnetic Resonance Spectroscopy - methods | Hydroxylation | Diethylamines - chemistry | Humans | Microsomes, Liver - metabolism | Cytochrome P-450 Enzyme System - metabolism | Risperidone - chemistry | Indenes - chemistry | Celecoxib - chemistry | Midazolam - chemistry | Halogenation | Pharmaceutical Preparations - chemistry | Fluorine - chemistry | Aldehydes - chemistry
MEDICINAL CHEMISTRY | PHENOLS | RAMELTEON | PHARMACOLOGY & PHARMACY | RISPERIDONE | EXCRETION | MIDAZOLAM | Magnetic Resonance Spectroscopy - methods | Hydroxylation | Diethylamines - chemistry | Humans | Microsomes, Liver - metabolism | Cytochrome P-450 Enzyme System - metabolism | Risperidone - chemistry | Indenes - chemistry | Celecoxib - chemistry | Midazolam - chemistry | Halogenation | Pharmaceutical Preparations - chemistry | Fluorine - chemistry | Aldehydes - chemistry
Journal Article
International Journal of Pharmaceutics, ISSN 0378-5173, 01/2014, Volume 461, Issue 1-2, pp. 258 - 269
Polymeric microparticles have been used widely for sustained drug delivery. Current methods of microparticle production can be improved by making homogeneous...
Methylprednisolone acetate | PVA template method | PLGA microparticle | Risperidone | Controlled release | Paclitaxel | IN-VITRO RELEASE | Met hylprednisolone acetate | STABILITY | SOLVENT SELECTION | SIZE | ENCAPSULATION | FORMULATION | VANCOMYCIN | PLGA MICROSPHERES | DEGRADATION | PHARMACOLOGY & PHARMACY | FABRICATION | microparticle | Viscosity | Polyvinyl Alcohol - chemistry | Lactic Acid - chemistry | Molecular Weight | Hydrogels | Drug Compounding - methods | Solvents - chemistry | Risperidone - administration & dosage | Risperidone - chemistry | Methylprednisolone - analogs & derivatives | Drug Carriers - chemistry | Drug Delivery Systems | Particle Size | Paclitaxel - chemistry | Polyglycolic Acid - chemistry | Polymers - chemistry | Paclitaxel - administration & dosage | Delayed-Action Preparations | Methylprednisolone - chemistry | Methylprednisolone - administration & dosage | Drugs | Drug delivery systems | Methods | Vehicles | methylprednisolone acetate | paclitaxel | controlled release | PLGA Microparticle | risperidone
Methylprednisolone acetate | PVA template method | PLGA microparticle | Risperidone | Controlled release | Paclitaxel | IN-VITRO RELEASE | Met hylprednisolone acetate | STABILITY | SOLVENT SELECTION | SIZE | ENCAPSULATION | FORMULATION | VANCOMYCIN | PLGA MICROSPHERES | DEGRADATION | PHARMACOLOGY & PHARMACY | FABRICATION | microparticle | Viscosity | Polyvinyl Alcohol - chemistry | Lactic Acid - chemistry | Molecular Weight | Hydrogels | Drug Compounding - methods | Solvents - chemistry | Risperidone - administration & dosage | Risperidone - chemistry | Methylprednisolone - analogs & derivatives | Drug Carriers - chemistry | Drug Delivery Systems | Particle Size | Paclitaxel - chemistry | Polyglycolic Acid - chemistry | Polymers - chemistry | Paclitaxel - administration & dosage | Delayed-Action Preparations | Methylprednisolone - chemistry | Methylprednisolone - administration & dosage | Drugs | Drug delivery systems | Methods | Vehicles | methylprednisolone acetate | paclitaxel | controlled release | PLGA Microparticle | risperidone
Journal Article
International Journal of Biological Macromolecules, ISSN 0141-8130, 07/2015, Volume 78, pp. 102 - 111
A novel alginate gel-coated oil-entrapped calcium-alginate–tamarind gum (TG)–magnesium stearate (MS) composite floating beads was developed for intragastric...
Tamarind gum | Emulsion gel beads | Alginate | SYSTEM | MUCOADHESIVE BEADS | HYDROGELS | METFORMIN HCL | DRUG-DELIVERY | BIOCHEMISTRY & MOLECULAR BIOLOGY | STERCULIA GUM | RELEASE | FORMULATION | IN-VITRO EVALUATION | OPTIMIZATION | Risperidone - administration & dosage | Hexuronic Acids - chemistry | Plant Gums - chemistry | Spectroscopy, Fourier Transform Infrared | Stearic Acids - chemistry | Chemistry, Pharmaceutical | Particle Size | Microspheres | Magnesium - chemistry | X-Ray Diffraction | Alginates - chemistry | Drug Liberation | Gels - chemistry | Tamarindus - chemistry | Glucuronic Acid - chemistry | Drugstores | Antipsychotic drugs | Magnesium compounds | Pharmacy
Tamarind gum | Emulsion gel beads | Alginate | SYSTEM | MUCOADHESIVE BEADS | HYDROGELS | METFORMIN HCL | DRUG-DELIVERY | BIOCHEMISTRY & MOLECULAR BIOLOGY | STERCULIA GUM | RELEASE | FORMULATION | IN-VITRO EVALUATION | OPTIMIZATION | Risperidone - administration & dosage | Hexuronic Acids - chemistry | Plant Gums - chemistry | Spectroscopy, Fourier Transform Infrared | Stearic Acids - chemistry | Chemistry, Pharmaceutical | Particle Size | Microspheres | Magnesium - chemistry | X-Ray Diffraction | Alginates - chemistry | Drug Liberation | Gels - chemistry | Tamarindus - chemistry | Glucuronic Acid - chemistry | Drugstores | Antipsychotic drugs | Magnesium compounds | Pharmacy
Journal Article
6.
Full Text
Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidone
Nature, ISSN 0028-0836, 03/2018, Volume 555, Issue 7695, pp. 269 - 273
Dopamine is a neurotransmitter that has been implicated in processes as diverse as reward, addiction, control of coordinated movement, metabolism and hormonal...
LIGANDS | CLONING | CRYSTAL-STRUCTURE | PHARMACOLOGY | MULTIDISCIPLINARY SCIENCES | CHARGES | RHODOPSIN | MODEL | BETA-ADRENERGIC RECEPTOR | DISCOVERY | AGONIST | Receptors, Dopamine D4 - chemistry | Humans | Receptors, Dopamine D3 - chemistry | Receptors, Dopamine D3 - metabolism | Mutant Proteins - genetics | Models, Molecular | Crystallography, X-Ray | Mutant Proteins - metabolism | Risperidone - chemistry | Receptors, Dopamine D2 - metabolism | Receptors, Dopamine D2 - genetics | Antipsychotic Agents - chemistry | Mutant Proteins - chemistry | Drug Design | Hydrophobic and Hydrophilic Interactions | Receptors, Dopamine D2 - chemistry | Antipsychotic Agents - metabolism | Ligands | Receptors, Dopamine D4 - metabolism | Risperidone - metabolism | Kinetics | Mutation | Binding Sites | Pharmacology, Experimental | Drug interactions | Physiological aspects | Research | Risperidone | Structure | Dopamine receptors | Drugs | Attention deficit disorder | Neuroleptics | Parkinson's disease | Molecular structure | Mental disorders | Parkinsons disease | Schizophrenia | Mental depression | Proteins | Psychotropic drugs | Receptors | Vomiting | Reinforcement | Dopamine D2 receptors | Movement disorders | Crystal structure | Dopamine | Neurodegenerative diseases | Secretion | Attention deficit hyperactivity disorder | Nausea | Metabolism | Side effects | Addiction | Structure-function relationships
LIGANDS | CLONING | CRYSTAL-STRUCTURE | PHARMACOLOGY | MULTIDISCIPLINARY SCIENCES | CHARGES | RHODOPSIN | MODEL | BETA-ADRENERGIC RECEPTOR | DISCOVERY | AGONIST | Receptors, Dopamine D4 - chemistry | Humans | Receptors, Dopamine D3 - chemistry | Receptors, Dopamine D3 - metabolism | Mutant Proteins - genetics | Models, Molecular | Crystallography, X-Ray | Mutant Proteins - metabolism | Risperidone - chemistry | Receptors, Dopamine D2 - metabolism | Receptors, Dopamine D2 - genetics | Antipsychotic Agents - chemistry | Mutant Proteins - chemistry | Drug Design | Hydrophobic and Hydrophilic Interactions | Receptors, Dopamine D2 - chemistry | Antipsychotic Agents - metabolism | Ligands | Receptors, Dopamine D4 - metabolism | Risperidone - metabolism | Kinetics | Mutation | Binding Sites | Pharmacology, Experimental | Drug interactions | Physiological aspects | Research | Risperidone | Structure | Dopamine receptors | Drugs | Attention deficit disorder | Neuroleptics | Parkinson's disease | Molecular structure | Mental disorders | Parkinsons disease | Schizophrenia | Mental depression | Proteins | Psychotropic drugs | Receptors | Vomiting | Reinforcement | Dopamine D2 receptors | Movement disorders | Crystal structure | Dopamine | Neurodegenerative diseases | Secretion | Attention deficit hyperactivity disorder | Nausea | Metabolism | Side effects | Addiction | Structure-function relationships
Journal Article
Journal of Microencapsulation, ISSN 0265-2048, 04/2016, Volume 33, Issue 3, pp. 199 - 208
The paper is devoted to the investigation of the effect of polyester hydrophobicity and ability for crystallisation on lipophilic drug loading and release from...
Biodegradable particles | drug release | drug encapsulation | risperidone | POLY(L-LACTIDE) | CRYSTALLINITY | MICROSPHERES | POLYMERIZATION | DELIVERY | ENGINEERING, CHEMICAL | NANOPARTICLES | IN-VITRO | PHARMACOLOGY & PHARMACY | CHEMISTRY, APPLIED | Lactic Acid - chemistry | Humans | Risperidone - administration & dosage | Crystallization | Delayed-Action Preparations - chemistry | Risperidone - chemistry | Dopamine Antagonists - administration & dosage | Antipsychotic Agents - administration & dosage | Polyesters - chemistry | Antipsychotic Agents - chemistry | Macrolides - chemistry | U937 Cells | Polyglycolic Acid - chemistry | Drug Liberation | Hydrophobic and Hydrophilic Interactions | Dopamine Antagonists - chemistry
Biodegradable particles | drug release | drug encapsulation | risperidone | POLY(L-LACTIDE) | CRYSTALLINITY | MICROSPHERES | POLYMERIZATION | DELIVERY | ENGINEERING, CHEMICAL | NANOPARTICLES | IN-VITRO | PHARMACOLOGY & PHARMACY | CHEMISTRY, APPLIED | Lactic Acid - chemistry | Humans | Risperidone - administration & dosage | Crystallization | Delayed-Action Preparations - chemistry | Risperidone - chemistry | Dopamine Antagonists - administration & dosage | Antipsychotic Agents - administration & dosage | Polyesters - chemistry | Antipsychotic Agents - chemistry | Macrolides - chemistry | U937 Cells | Polyglycolic Acid - chemistry | Drug Liberation | Hydrophobic and Hydrophilic Interactions | Dopamine Antagonists - chemistry
Journal Article
Carbohydrate Polymers, ISSN 0144-8617, 04/2015, Volume 120, pp. 74 - 84
Novel floating-mucoadhesive oil-entrapped alginate beads coated with crossslinked alginate–sterculia gum gel membrane was developed for gastroretentive...
Alginate | Olive oil | Floatation | Mucoadhesion | Risperidone | Sterculia gum | SYSTEM | MUCOADHESIVE | POLYMER SCIENCE | MICROSPHERES | DRUG-DELIVERY | CALCIUM SILICATE | CHEMISTRY, ORGANIC | RELEASE | FORMULATION | IN-VITRO EVALUATION | CHEMISTRY, APPLIED | Microspheres | Serotonin Antagonists - administration & dosage | Alginates - chemistry | Risperidone - administration & dosage | Sterculia - chemistry | Hexuronic Acids - chemistry | Oils - chemistry | Glucuronic Acid - chemistry | Drugstores | Pharmacy | Antipsychotic drugs
Alginate | Olive oil | Floatation | Mucoadhesion | Risperidone | Sterculia gum | SYSTEM | MUCOADHESIVE | POLYMER SCIENCE | MICROSPHERES | DRUG-DELIVERY | CALCIUM SILICATE | CHEMISTRY, ORGANIC | RELEASE | FORMULATION | IN-VITRO EVALUATION | CHEMISTRY, APPLIED | Microspheres | Serotonin Antagonists - administration & dosage | Alginates - chemistry | Risperidone - administration & dosage | Sterculia - chemistry | Hexuronic Acids - chemistry | Oils - chemistry | Glucuronic Acid - chemistry | Drugstores | Pharmacy | Antipsychotic drugs
Journal Article
Psychopharmacology, ISSN 0033-3158, 12/2017, Volume 234, Issue 23, pp. 3507 - 3520
Racemic (RS)-amisulpride (Solian®) is an atypical antipsychotic drug used to treat schizophrenia and dysthymia. Blockade of dopamine D2/D3 and/or serotonin...
Drug discrimination | Neurosciences | Amisulpride | Schizophrenia | Isomers | Anxiolytics | Discriminative stimulus | Antipsychotics | Biomedicine | Antidepressants | C57BL/6 mice | Benzamides | Pharmacology/Toxicology | Psychiatry | CORTICAL MEMBRANES | PSYCHIATRY | HIGH-AFFINITY | MAJOR DEPRESSION | D-2 RECEPTORS | NEUROSCIENCES | RECEPTOR ANTAGONIST | LIMBIC SELECTIVITY | 5-HT7 RECEPTOR | PHARMACOLOGY & PHARMACY | MOLECULAR-CLONING | RAT-BRAIN | DOPAMINE-RECEPTORS | Sulpiride - pharmacology | Conditioning, Operant - physiology | Male | Sulpiride - analogs & derivatives | Clozapine - pharmacology | Discrimination Learning - drug effects | Clozapine - chemistry | Conditioning, Operant - drug effects | Antidepressive Agents - chemistry | Anti-Anxiety Agents - chemistry | Antidepressive Agents - pharmacology | Benzamides - pharmacology | Quetiapine Fumarate - pharmacology | Benzamides - chemistry | Quetiapine Fumarate - chemistry | Mice, Inbred C57BL | Chlorpromazine - chemistry | Risperidone - pharmacology | Anti-Anxiety Agents - pharmacology | Chlorpromazine - pharmacology | Risperidone - chemistry | Discrimination Learning - physiology | Animals | Antipsychotic Agents - chemistry | Mice | Antipsychotic Agents - pharmacology | Sulpiride - chemistry | Dosage and administration | Antipsychotic drugs | Comparative analysis | Drug interactions | Antianxiety agents | Stereoisomers | Drugs | Neuroleptics | Olanzapine | Operant conditioning | Mental disorders | Aripiprazole | Benzamide | Metoclopramide | Chlorpromazine | Sulpiride | Serotonin S7 receptors | Psychotropic drugs | Imipramine | Receptors | Bupropion | Mianserin | Risperidone | Dopamine D2 receptors | Drug dosages | Quetiapine | Raclopride | Dopamine | Serotonin | Dopamine D3 receptors | Chlordiazepoxide | Pharmacology | Clozapine | Derivatives | Properties (attributes) | Serotonin receptors
Drug discrimination | Neurosciences | Amisulpride | Schizophrenia | Isomers | Anxiolytics | Discriminative stimulus | Antipsychotics | Biomedicine | Antidepressants | C57BL/6 mice | Benzamides | Pharmacology/Toxicology | Psychiatry | CORTICAL MEMBRANES | PSYCHIATRY | HIGH-AFFINITY | MAJOR DEPRESSION | D-2 RECEPTORS | NEUROSCIENCES | RECEPTOR ANTAGONIST | LIMBIC SELECTIVITY | 5-HT7 RECEPTOR | PHARMACOLOGY & PHARMACY | MOLECULAR-CLONING | RAT-BRAIN | DOPAMINE-RECEPTORS | Sulpiride - pharmacology | Conditioning, Operant - physiology | Male | Sulpiride - analogs & derivatives | Clozapine - pharmacology | Discrimination Learning - drug effects | Clozapine - chemistry | Conditioning, Operant - drug effects | Antidepressive Agents - chemistry | Anti-Anxiety Agents - chemistry | Antidepressive Agents - pharmacology | Benzamides - pharmacology | Quetiapine Fumarate - pharmacology | Benzamides - chemistry | Quetiapine Fumarate - chemistry | Mice, Inbred C57BL | Chlorpromazine - chemistry | Risperidone - pharmacology | Anti-Anxiety Agents - pharmacology | Chlorpromazine - pharmacology | Risperidone - chemistry | Discrimination Learning - physiology | Animals | Antipsychotic Agents - chemistry | Mice | Antipsychotic Agents - pharmacology | Sulpiride - chemistry | Dosage and administration | Antipsychotic drugs | Comparative analysis | Drug interactions | Antianxiety agents | Stereoisomers | Drugs | Neuroleptics | Olanzapine | Operant conditioning | Mental disorders | Aripiprazole | Benzamide | Metoclopramide | Chlorpromazine | Sulpiride | Serotonin S7 receptors | Psychotropic drugs | Imipramine | Receptors | Bupropion | Mianserin | Risperidone | Dopamine D2 receptors | Drug dosages | Quetiapine | Raclopride | Dopamine | Serotonin | Dopamine D3 receptors | Chlordiazepoxide | Pharmacology | Clozapine | Derivatives | Properties (attributes) | Serotonin receptors
Journal Article
International Journal of Pharmaceutics, ISSN 0378-5173, 09/2015, Volume 493, Issue 1-2, pp. 40 - 54
This paper describes design and evaluation of parenteral lecithin-based nanoemulsions intended for brain delivery of risperidone, a poorly water-soluble...
General factorial design | Brain targeting | Poorly water-soluble drugs | Parenteral nanoemulsions | Pharmacokinetics | Physical stability | LONG-TERM STABILITY | BLOCK-COPOLYMERS | DRUG-DELIVERY | RATS | FORMULATION | INTRAVENOUS LIPID EMULSION | NANOPARTICLES | PHYSICOCHEMICAL CHARACTERIZATION | PHARMACOLOGY & PHARMACY | OPTIMIZATION | ORAL DELIVERY | Poloxamer - chemistry | Nanoparticles - chemistry | Polysorbates - chemistry | Rats, Wistar | Emulsions - chemistry | Drug Stability | Risperidone - administration & dosage | Risperidone - pharmacokinetics | Solubility | Rats | Male | Polyethylene Glycols - chemistry | Stearic Acids - chemistry | Chemistry, Pharmaceutical | Drug Delivery Systems | Brain - metabolism | Particle Size | Technology, Pharmaceutical | Animals | Lecithins - chemistry | Emulsifying Agents | Drugstores | Pharmacy | Antipsychotic drugs
General factorial design | Brain targeting | Poorly water-soluble drugs | Parenteral nanoemulsions | Pharmacokinetics | Physical stability | LONG-TERM STABILITY | BLOCK-COPOLYMERS | DRUG-DELIVERY | RATS | FORMULATION | INTRAVENOUS LIPID EMULSION | NANOPARTICLES | PHYSICOCHEMICAL CHARACTERIZATION | PHARMACOLOGY & PHARMACY | OPTIMIZATION | ORAL DELIVERY | Poloxamer - chemistry | Nanoparticles - chemistry | Polysorbates - chemistry | Rats, Wistar | Emulsions - chemistry | Drug Stability | Risperidone - administration & dosage | Risperidone - pharmacokinetics | Solubility | Rats | Male | Polyethylene Glycols - chemistry | Stearic Acids - chemistry | Chemistry, Pharmaceutical | Drug Delivery Systems | Brain - metabolism | Particle Size | Technology, Pharmaceutical | Animals | Lecithins - chemistry | Emulsifying Agents | Drugstores | Pharmacy | Antipsychotic drugs
Journal Article
Forensic Science International, ISSN 0379-0738, 2016, Volume 274, pp. 33 - 37
Highlights • Antipsychotic and antidepressant treatment may be associated impaired glycemic control. • Reported complications included diabetic ketoacidosis...
Pathology | Antipsychotics | Glucose metabolism | Postmortem biochemistry | Antidepressants | Autopsy | INDUCED HYPERGLYCEMIC KETOACIDOSIS | MEDICINE, LEGAL | ONSET DIABETIC-KETOACIDOSIS | SCHIZOPHRENIA | RISPERIDONE | MELLITUS | HYPERTRIGLYCERIDEMIA | ATYPICAL ANTIPSYCHOTICS | OLANZAPINE TREATMENT | MIRTAZAPINE THERAPY | ACUTE-PANCREATITIS | Antipsychotic Agents - adverse effects | Bile - chemistry | Humans | Middle Aged | Pericardial Fluid - chemistry | Hair - chemistry | Male | Diabetes Mellitus | Liver - chemistry | Vitreous Body - chemistry | Diabetic Ketoacidosis | Young Adult | Antipsychotic Agents - analysis | Gastrointestinal Contents - chemistry | Muscle, Skeletal - chemistry | Glucose - metabolism | Adult | Female | Aged | Brain Chemistry | Retrospective Studies | Psychotropic drugs | Physiological aspects | Biochemistry | Research | Postmortem changes | Drugs | Neuroleptics | Olanzapine | Forensic engineering | Pathogenesis | Glucose | Drug development | Toxicology | Metabolites | Drug metabolism | Risperidone | Quetiapine | Autopsies | Forensic science | Complications | Diabetes mellitus | Mortality | Clozapine | Metabolism | Ketoacidosis | Fatalities | Death | Index Medicus
Pathology | Antipsychotics | Glucose metabolism | Postmortem biochemistry | Antidepressants | Autopsy | INDUCED HYPERGLYCEMIC KETOACIDOSIS | MEDICINE, LEGAL | ONSET DIABETIC-KETOACIDOSIS | SCHIZOPHRENIA | RISPERIDONE | MELLITUS | HYPERTRIGLYCERIDEMIA | ATYPICAL ANTIPSYCHOTICS | OLANZAPINE TREATMENT | MIRTAZAPINE THERAPY | ACUTE-PANCREATITIS | Antipsychotic Agents - adverse effects | Bile - chemistry | Humans | Middle Aged | Pericardial Fluid - chemistry | Hair - chemistry | Male | Diabetes Mellitus | Liver - chemistry | Vitreous Body - chemistry | Diabetic Ketoacidosis | Young Adult | Antipsychotic Agents - analysis | Gastrointestinal Contents - chemistry | Muscle, Skeletal - chemistry | Glucose - metabolism | Adult | Female | Aged | Brain Chemistry | Retrospective Studies | Psychotropic drugs | Physiological aspects | Biochemistry | Research | Postmortem changes | Drugs | Neuroleptics | Olanzapine | Forensic engineering | Pathogenesis | Glucose | Drug development | Toxicology | Metabolites | Drug metabolism | Risperidone | Quetiapine | Autopsies | Forensic science | Complications | Diabetes mellitus | Mortality | Clozapine | Metabolism | Ketoacidosis | Fatalities | Death | Index Medicus
Journal Article
Acta Pharmaceutica, ISSN 1330-0075, 12/2015, Volume 65, Issue 4, pp. 365 - 382
This study was aimed at developing risperidone oral disintegrating mini-tablets (OD-mini-tablets) as age-appropriate formulations and to assess their...
mini-tablets | optimization design | disintegration | risperidone | pediatrics | PHARMACOLOGY & PHARMACY | SALIVA | Pediatrics | Age Factors | Tablets | Humans | Child, Preschool | Infant | Saliva - chemistry | Spectroscopy, Fourier Transform Infrared | Cellulose - chemistry | Excipients - chemistry | Surface Properties | Child | Administration, Oral | Risperidone - administration & dosage | Silicon Dioxide - chemistry | Solubility | Risperidone - chemistry | Chemistry, Pharmaceutical | Antipsychotic Agents - administration & dosage | Povidone - chemistry | Starch - analogs & derivatives | Starch - chemistry | Antipsychotic Agents - chemistry | Mannitol - chemistry | Kinetics
mini-tablets | optimization design | disintegration | risperidone | pediatrics | PHARMACOLOGY & PHARMACY | SALIVA | Pediatrics | Age Factors | Tablets | Humans | Child, Preschool | Infant | Saliva - chemistry | Spectroscopy, Fourier Transform Infrared | Cellulose - chemistry | Excipients - chemistry | Surface Properties | Child | Administration, Oral | Risperidone - administration & dosage | Silicon Dioxide - chemistry | Solubility | Risperidone - chemistry | Chemistry, Pharmaceutical | Antipsychotic Agents - administration & dosage | Povidone - chemistry | Starch - analogs & derivatives | Starch - chemistry | Antipsychotic Agents - chemistry | Mannitol - chemistry | Kinetics
Journal Article
International Journal of Pharmaceutics, ISSN 0378-5173, 2011, Volume 420, Issue 2, pp. 198 - 205
The current manuscript addresses the need for a validated release testing method for controlled release parenteral microspheres. A USP apparatus 4 method was...
Validation | In vitro release | USP apparatus 4 | PLGA microspheres | DEGRADATION | PHARMACOLOGY & PHARMACY | MICROCAPSULES | Reproducibility of Results | Temperature | Chemistry, Pharmaceutical - methods | Lactic Acid - chemistry | Molecular Weight | Delayed-Action Preparations - chemistry | Risperidone - chemistry | Drug Carriers - chemistry | Chemistry, Pharmaceutical - instrumentation | Microspheres | Antipsychotic Agents - chemistry | Polyglycolic Acid - chemistry | Hydrogen-Ion Concentration
Validation | In vitro release | USP apparatus 4 | PLGA microspheres | DEGRADATION | PHARMACOLOGY & PHARMACY | MICROCAPSULES | Reproducibility of Results | Temperature | Chemistry, Pharmaceutical - methods | Lactic Acid - chemistry | Molecular Weight | Delayed-Action Preparations - chemistry | Risperidone - chemistry | Drug Carriers - chemistry | Chemistry, Pharmaceutical - instrumentation | Microspheres | Antipsychotic Agents - chemistry | Polyglycolic Acid - chemistry | Hydrogen-Ion Concentration
Journal Article
Journal of Pharmaceutical Sciences, ISSN 0022-3549, 11/2017, Volume 106, Issue 11, pp. 3363 - 3371
Ultrafine particle processing system (UPPS) was developed previously by our group to provide a new solution to microsphere fabrication. The UPPS was supposed...
drug delivery systems | controlled release | microspheres | dissolution | material science | CHEMISTRY, MEDICINAL | VIVO | NANOFIBERS | SIZE | RELEASE | FORMULATION | CHEMISTRY, MULTIDISCIPLINARY | DELIVERY | NANOPARTICLES | REACTOR | SOLVENTS | PHARMACOLOGY & PHARMACY | MICROENCAPSULATION | Viscosity | Lactic Acid - chemistry | Drug Compounding - methods | Risperidone - administration & dosage | Delayed-Action Preparations - chemistry | Risperidone - chemistry | Antipsychotic Agents - administration & dosage | Particle Size | Microspheres | Antipsychotic Agents - chemistry | Polyglycolic Acid - chemistry | Surface Properties | Drug Liberation | Diffusion
drug delivery systems | controlled release | microspheres | dissolution | material science | CHEMISTRY, MEDICINAL | VIVO | NANOFIBERS | SIZE | RELEASE | FORMULATION | CHEMISTRY, MULTIDISCIPLINARY | DELIVERY | NANOPARTICLES | REACTOR | SOLVENTS | PHARMACOLOGY & PHARMACY | MICROENCAPSULATION | Viscosity | Lactic Acid - chemistry | Drug Compounding - methods | Risperidone - administration & dosage | Delayed-Action Preparations - chemistry | Risperidone - chemistry | Antipsychotic Agents - administration & dosage | Particle Size | Microspheres | Antipsychotic Agents - chemistry | Polyglycolic Acid - chemistry | Surface Properties | Drug Liberation | Diffusion
Journal Article